“Clinical outcome of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma: a Comparative study in Dhaka, Bangladesh”, Sir Salimullah Med. Coll. J., vol. 32, no. 2, pp. 59–64, Oct. 2025, doi: 10.3329/ssmcj.v32i2.84524.